Group of Medicinal Chemistry of Sulfur and Selenium Compounds

In our group we research in the design, synthesis an biological evaluation of novel sulfur- and/or selenium-containing organic compounds. Our goal is to obtain novel active sulfur compounds and selenocompounds with potential applications in the treatment of diseases. The diseases in which we focus in our research work are: -Cancer: compounds with antiproliferative, cytotoxic and/or chemopreventive activity in cancer. -Multidrug resistant cancer: compounds that can reverse the tumour mechanisms responsible of the resistance to chemotherapy drugs. -Infections: compounds with antibacterial, antiviral and/or antiparasitary activity. -Bacterial resistant infections: compounds that can reverse the bacterial mechanisms responsible of the resistance to antibiotics.